Adtalem Global Education (NYSE:CVSA) Upgraded by Wall Street Zen to “Buy” Rating

Adtalem Global Education (NYSE:CVSA) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Several other equities analysts have also recently weighed in on CVSA. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Barrington Research reiterated an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Truist Financial lifted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Stock Performance

NYSE CVSA opened at $128.23 on Friday. The company has a market capitalization of $4.36 billion, a PE ratio of 19.97, a P/E/G ratio of 1.09 and a beta of 0.62. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26. The firm has a fifty day moving average of $120.70. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.Adtalem Global Education’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, research analysts forecast that Adtalem Global Education will post 8.04 earnings per share for the current year.

Insider Activity

In other news, CEO Stephen W. Beard sold 15,874 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $131.25, for a total transaction of $2,083,462.50. Following the transaction, the chief executive officer directly owned 429,324 shares in the company, valued at $56,348,775. The trade was a 3.57% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Karen Sue Cox sold 2,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $124.50, for a total transaction of $249,000.00. Following the transaction, the insider owned 31,596 shares in the company, valued at approximately $3,933,702. This represents a 5.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 42,780 shares of company stock valued at $5,506,145. 2.50% of the stock is currently owned by company insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.